Generalizability of molecular docking predictions across novel protein targets and distinct small-molecule chemotypes is key to the successful application of deep learning co-folding approaches in drug discovery, as highlighted by recent benchmarks, including Runs-n-Poses [Škrinjar, P.; et al.Nat. Struct. Mol. Biol.2026, 33, 782–794.]. To compare generalizability across physics-based, hybrid rescoring models, and co-folding approaches, we systematically benchmarked several molecular docking tools representing these paradigms. Our results support previous observations that co-folding approaches show superior performance on targets resembling their training datasets. However, they deteriorate sharply to unacceptably low 20–40% success rates on novel dissimilar systems, consistent with memorization. In contrast, physics-based and hybrid methods exhibit greater out-of-distribution robustness, maintaining more than 60% success rates for docking protein–ligand complexes with minimal similarity to previously known complexes. Our results highlight the complementarity of AI-based approaches and methods based on physical sampling in all-atom models, in terms of their applicability range, and argue for the benefits of tighter integration.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: